Evidence map›Paper›PMID 37468185›Full record

Trial reportJournal of the American College of Cardiology2023

Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.

Kreton Mavromatis, Philip G Jones, Ziad A Ali, Gregg W Stone, Grace M Rhodes, Sripal Bangalore, Sean O'Brien, Philippe Genereux, Jennifer Horst, Ovidiu Dressler and 13 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01471522 (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01471522 nacompletednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

TypeinterventionalSponsorNYU Langone HealthRan2012 to 2023Enrolled5,179ConditionsCardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart DiseasesArmscardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Sex differences in coronary disease health Status outcomes: the ISCHEMIA trial.European heart journal. Quality of care & clinical outcomes · 2026
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Characterizing heterogeneity in health-related quality of life trajectories in coronary artery disease: a longitudinal latent Markov analysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Vascular (dys)function in the failing heart.Nature reviews. Cardiology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 4 countries.

Kreton MavromatisEmory University, Atlanta VA Healthcare System, Atlanta, Georgia, USA. Electronic address: kmavro@emory.edu.
Philip G JonesSaint Luke's Mid America Heart Institute/University of Missouri - Kansas City (UMKC), Kansas City, Missouri, USA.
Ziad A AliSt Francis Hospital and Heart Center, Roslyn, New York, USA; Cardiovascular Research Foundation, New York, New York, USA.
Gregg W StoneThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Grace M RhodesDuke Clinical Research Institute, Durham, North Carolina, USA.
Sripal BangaloreNYU Grossman School of Medicine, New York, New York, USA.
Sean O'BrienDuke Clinical Research Institute, Durham, North Carolina, USA.
Philippe GenereuxGagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
Jennifer HorstCardiovascular Research Foundation, New York, New York, USA.
Ovidiu DresslerCardiovascular Research Foundation, New York, New York, USA.
Shaun GoodmanSt Michael's Hospital, University of Toronto, and the Canadian Heart Research Centre, Toronto, Ontario, Canada.
Karen AlexanderDuke Clinical Research Institute, Durham, North Carolina, USA.
Anoop MathewUniversity of Alberta Hospital, Edmonton, Alberta, Canada.
Jiyan ChenGuangdong Provincial People's Hospital, Guangdong, China.
Balram BhargavaAll India Institute of Medical Science, New Delhi, India.
Amar UxaUniversity of Toronto and University Health Network/Mount Sinai Hospital, Toronto, Ontario, Canada.
William E BodenVA New England Healthcare System, Bedford, Massachusetts, USA.
Daniel B MarkDuke Clinical Research Institute, Durham, North Carolina, USA.
Harmony R ReynoldsNYU Grossman School of Medicine, New York, New York, USA.
David J MaronDepartment of Medicine, Stanford University, Stanford, California, USA.
Judith S HochmanNYU Grossman School of Medicine, New York, New York, USA.
John A SpertusSaint Luke's Mid America Heart Institute/University of Missouri - Kansas City (UMKC), Kansas City, Missouri, USA.
ISCHEMIA Research Group
Clinical Research Institute · USNew York University · USCardiovascular Research Foundation · USSaint Luke's Hospital · USAlberta Hospital Edmonton · CAAll India Institute of Medical Sciences · INCardiovascular Institute of the South · USEmory Healthcare · USGuangdong Provincial People's Hospital · CNMorristown Medical Center · USMount Sinai Hospital · CAStanford University · USSt. Francis Hospital · USSt. Michael's Hospital · CAVA New England Healthcare System · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
The ISCHEMIA Trial - SDCCU01HL105462 · NHLBI · DUKE UNIVERSITY · PI ALEXANDER, KAREN P, O'BRIEN, SEAN M · 2011 to 2019
$17.8M
THE ISCHEMIA TRIAL - IICCU01HL105561 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHAW, LESLEE J · 2011 to 2018
$6.5M
Integrated Biostatistical Training for CVD ResearchT32HL079896 · NHLBI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sean M O'Brien, Ana-Maria Staicu · 2006 to 2026
$4.1M
The ISCHEMIA Trial - EQOLU01HL105565 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2011 to 2017
$2.4M
NCATS NIH HHS UL1 TR001445NCATS NIH HHS UL1 TR002243NHLBI NIH HHS T32 HL079896NHLBI NIH HHS U01 HL105462NHLBI NIH HHS U01 HL105561NHLBI NIH HHS U01 HL105565NHLBI NIH HHS U01 HL105907
6 · The paper itself

Abstract

backgroundThe impact of complete revascularization (CR) on angina-related health status (symptoms, function, quality of life) in chronic coronary disease (CCD) has not been well studied.

objectivesAmong patients with CCD randomized to invasive (INV) vs conservative (CON) management in ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches), we compared the following: 1) the impact of anatomic and functional CR on health status compared with incomplete revascularization (ICR); and 2) the predicted impact of achieving CR in all INV patients compared with CON.

methodsMultivariable regression adjusting for patient characteristics was used to compare 12-month health status after independent core laboratory-defined CR vs ICR in INV patients who underwent revascularization. Propensity-weighted modeling was then performed to estimate the treatment effect had CR or ICR been achieved in all INV patients, compared with CON.

resultsAnatomic and functional CR were achieved in 43.3% and 57.8% of 1,641 INV patients, respectively. Among revascularized patients, CR was associated with improved Seattle Angina Questionnaire Angina Frequency compared with ICR after adjustment for baseline differences. After modeling CR and ICR in all INV patients, patients with CR and ICR each had greater improvements in health status than CON, with better health status with CR than ICR. The projected benefits of CR were most pronounced in patients with baseline daily/weekly angina and not seen in those with no angina.

conclusionsAmong patients with CCD in ISCHEMIA, health status improved more with CR compared with ICR or CON, particularly in those with frequent angina. Anatomic and functional CR provided comparable improvements in quality of life. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

Indexed as

Coronary Artery DiseaseQuality of LifeAngina PectorisHealth StatusHumansIschemiaMyocardial RevascularizationTreatment Outcomecomplete revascularizationcoronary artery diseaseischemiaquality of liferevascularization

Identifiers

PMID37468185
PMCPMC10551823
OpenAlexW4384500742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.